The Manufacturing Backbone: Why Blow-Fill-Seal Is Central to a Secure Sterile Supply Chain From the technology to the fill line to commercial supply, a practical look at what BFS offers for preservative-free products.…
How Integrated pDNA-to-mRNA-LNP Manufacturing Reduces CDMO Handoffs Discover how BioCina’s integrated pDNA-to-mRNA-LNP manufacturing approach helps reduce CDMO handoffs, streamline supply chain coordination, and support manufacturing continuity. Explore…
BioCina CDMO Capabilities Overview Download BioCina’s CDMO capabilities overview, covering drug substance manufacturing in Adelaide and sterile drug product fill-finish in Perth.…
Restricted Access Barrier System (RABS) Explore how BioCina’s restricted access barrier system (RABS) in Perth separates operators from the critical zone during aseptic filling of…
SA25 Aseptic Filling Workcell Learn how BioCina’s SA25 Aseptic Filling Workcell in Perth uses gloveless robotics to fill vials, syringes and cartridges, helping reduce…
BioCina: End-to-End Global CDMO, Anchored in Australia Discover how BioCina, one integrated global CDMO with operations in Australia, connects drug substance and sterile drug product manufacturing.…
LNP Formulation Development: From Lipid Screening to cGMP Manufacturing Explore BioCina’s LNP formulation development and manufacturing capabilities, from lipid screening and encapsulation to scalable cGMP production. Discover how our…
cGMP Plasmid DNA Manufacturing: Process, Scale and CDMO Capabilities BioCina is a cGMP pDNA manufacturing CDMO providing scalable E. coli microbial fermentation (400mL–500L) for mRNA templates & viral vectors.…
Scaling cGMP mRNA Drug Substance Manufacturing: Process, Quality, and CDMO Selection Learn how an integrated mRNA drug substance CDMO streamlines IVT, LNP formulation, and tech transfer. Explore BioCina’s Adelaide suite capabilities.…